Gennao Bio
United States · $55.0M raised
- Employees
- 1–10
- Business Model
- B2B
- Website
- gennaobio.com
- Total Funding
- $55.0M
- Last Round
- $15.0M Venture RoundNov 2022
- Rounds
- 2
About
Genetic medicines company developing targeted nucleic acid therapeutics using antibody-drug conjugate platform.
Summary
Gennao Bio is a Biotech company based in United States. It has raised $55.0M in total across 2 rounds, most recently a $15.0M Venture Round round in Nov 2022. Investors include Logos Capital, OrbiMed and Surveyor Capital.
Tech & App Stack
7 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2022
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...